Molecular Pathology of Colorectal Cancer

Pathology Clinical Conference

Wednesday November 1, 2017 at 12:00 PM


This grand round has already taken place.


University Hospital - Stony Brook, NY
November 1st, 2017
1.00 AMA PRA Category 1 Credit Hours

Description

Colorectal cancer (CRC) is the second most commonly diagnosed cancer among females and third among males worldwide. Biomarkers currently play an important role in the detection and treatment of patients with colorectal cancer. There are attempts to personalize chemotherapy based on presence or absence of specific biomarkers. In this talk, I will describe current understanding of tumor markers and biomarkers role in CRC screening, diagnosis, treatment, and follow-up.

Dates and Times

Start: 11/1/2017 12:00 PM
End: 11/1/2017 1:00 PM

Objectives

1) How to test for a MMR deficient tumor
2) Molecular subtype of colorectal cancer
3) Predictive biomarkers for immunotherapy of colorectal cancer

Speakers

  • Dr. Yi Wang
    • Molecular Pathology of Colorectal Cancer

Location

University Hospital
Level 2, Room 749
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.